Myovant Sciences Ltd. Increase (Decrease) in Other Operating Assets
Myovant Sciences Ltd. reported Increase (Decrease) in Other Operating Assets of -$9.74 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2023-01-26
- Myovant Sciences Ltd. increase (decrease) in other operating assets for the quarter ending 2022-12-31 was -$1.34M, a 124.62% decline year-over-year.
- Myovant Sciences Ltd. increase (decrease) in other operating assets for the quarter ending 2022-09-30 was -$8.01M.
- Myovant Sciences Ltd. increase (decrease) in other operating assets for the quarter ending 2022-06-30 was -$392.00K.
- Myovant Sciences Ltd. increase (decrease) in other operating assets for the quarter ending 2022-03-31 was $2.78M, a 2006.06% increase year-over-year.
- Myovant Sciences Ltd. increase (decrease) in other operating assets for fiscal 2022 was $6.42M, a 345.59% increase from fiscal 2021.
- Myovant Sciences Ltd. increase (decrease) in other operating assets for fiscal 2021 was $1.44M, a 14310.00% increase from fiscal 2020.
- Myovant Sciences Ltd. increase (decrease) in other operating assets for fiscal 2020 was $10.00K.
- Myovant Sciences Ltd. increase (decrease) in other operating assets for fiscal 2019 was -$76.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26 | -$9.35M derived: sum of 2 quarters · filed 2023-01-26 | -$9.74M 10-Q · filed 2023-01-26 | -$6.96M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-09-30 | -$8.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26 | -$8.40M 10-Q · filed 2022-10-26 | -$5.62M derived: sum of 3 quarters · filed 2022-10-26 | -$180.00K derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-06-30 | -$392.00K 10-Q · filed 2022-07-27 | $2.39M derived: sum of 2 quarters · filed 2022-07-27 | $7.83M derived: sum of 3 quarters · filed 2023-01-26 | $6.14M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-03-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $8.22M derived: sum of 2 quarters · filed 2023-01-26 | $6.53M derived: sum of 3 quarters · filed 2023-01-26 | $6.42M 10-K · filed 2022-05-11 |
| 2021-12-31 | $5.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26 | $3.75M derived: sum of 2 quarters · filed 2023-01-26 | $3.64M 10-Q · filed 2023-01-26 | $3.77M derived: sum of 4 quarters · filed 2023-01-26 |
| 2021-09-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26 | -$1.80M 10-Q · filed 2022-10-26 | -$1.67M derived: sum of 3 quarters · filed 2022-10-26 | -$1.00M derived: sum of 4 quarters · filed 2022-10-26 |
| 2021-06-30 | -$112.00K 10-Q · filed 2022-07-27 | $20.00K derived: sum of 2 quarters · filed 2022-07-27 | $681.00K derived: sum of 3 quarters · filed 2022-07-27 | $1.33M derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-03-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $793.00K derived: sum of 2 quarters · filed 2022-05-11 | $1.44M derived: sum of 3 quarters · filed 2022-05-11 | $1.44M 10-K · filed 2022-05-11 |
| 2020-12-31 | $661.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-26 | $1.31M derived: sum of 2 quarters · filed 2022-01-26 | $1.31M 10-Q · filed 2022-01-26 | |
| 2020-09-30 | $648.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-10-26 | $648.00K 10-Q · filed 2021-10-26 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-28 | |||
| 2020-03-31 | $10.00K 10-K · filed 2022-05-11 | |||
| 2019-03-31 | -$76.00K 10-K · filed 2021-05-11 |